Italy· 044839025
WAKIX*30 cpr rivestite 18 mg flacone
A pitolisant product containing pitolisant, registered in Italy by BIOPROJET PHARMA, on the national reimbursement list. The same ATC class is registered in 15 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Pitolisant is registered in 15 of 19 countries.
Countries holding a registration under ATC N07XX11 (pitolisant), each read from that country’s own register.
- This record: Italy
- 10 of them publish a price we can compare per daily dose
Pitolisant · ATC N07XX11
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of pitolisant costs, country by country.
Normalised to the WHO defined daily dose (18 mg), the median price runs from $21.04 in France to $43.24 in Italy — a ×2.1 gap.
- Italy: $43.24 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Pitolisant · price per daily dose (18 mg)
USD · FX 28 Sept 2026
- IT Italy$43.24
- FR France$21.04
The record
At a glance
- Active substance
- Pitolisant
- Manufacturer
- BIOPROJET PHARMA
- Country
- Italy (IT)
- ATC code
- N07XX11
- ATC class
- Pitolisant
- Defined daily dose
- 18 mg, O
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic044839025WAKIX*30 cpr rivestite 18 mg flaconeEUR 581.87
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
272 interactions on record for pitolisant.
Graded by severity as the source publishes them — 49 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Pitolisant · interactions on record
272 records
- 49 severe
- 221 moderate
- 2 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- PapaverinC04AX38severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Pitolisant in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaOZAWADEBioprojet Pharma, Paříž
- BelgiumOzawade 18 mgBioprojet Pharma
- IcelandOzawadeBioprojet Pharma
- NetherlandsOzawade 18 mg filmomhulde tablettenBioprojet Pharma
- NorwayWakixAbacus Medicine A/S
- PolandOzawadeBioprojet Pharma
- SwedenOzawade 18 mg Filmdragerad tablettBioprojet Pharma
- SpainOZAWADE 18 MG COMPRIMIDOS RECUBIERTOS CON PELICULABioprojet Pharma
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Ozawade, Wakix
- Liechtenstein · Ozawade, Wakix
- Norway · Ozawade, Wakix
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ee5936db-2d6c-4b8e-ad79-60a26ddcc5c2 GET /v1/drugs/ee5936db-2d6c-4b8e-ad79-60a26ddcc5c2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 581.87,
"source": "aifa",
"currency": "EUR",
"strength": "PITOLISANT 18MG 30 UNITA' USO ORALE",
"substance": "Pitolisant",
"equivalence_group": "JTH",
"transparency_flag": null
}See everything about pitolisant.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.